BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29165437)

  • 21. Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease.
    Nevoux J; Nowak C; Vellin JF; Lepajolec C; Sterkers O; Richard S; Bobin S
    Otol Neurotol; 2014 Jun; 35(5):899-904. PubMed ID: 24662627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis, and treatment.
    Kim HJ; Butman JA; Brewer C; Zalewski C; Vortmeyer AO; Glenn G; Oldfield EH; Lonser RR
    J Neurosurg; 2005 Mar; 102(3):503-12. PubMed ID: 15796386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endolymphatic sac carcinoma of the right petrous bone in Von Hippel-Lindau disease.
    Muzumdar DP; Goel A; Fattepurkar S; Goel N
    J Clin Neurosci; 2006 May; 13(4):471-4. PubMed ID: 16678727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: an immunohistochemical study.
    Horiguchi H; Sano T; Toi H; Kageji T; Hirokawa M; Nagahiro S
    Mod Pathol; 2001 Jul; 14(7):727-32. PubMed ID: 11455007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging detection of endolymphatic sac tumor-associated hydrops.
    Butman JA; Nduom E; Kim HJ; Lonser RR
    J Neurosurg; 2013 Aug; 119(2):406-11. PubMed ID: 23472846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.
    Kim HJ; Hagan M; Butman JA; Baggenstos M; Brewer C; Zalewski C; Linehan WM; Lonser RR
    Laryngoscope; 2013 Feb; 123(2):477-83. PubMed ID: 23070752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adenocarcinoma of the endolymphatic sac in von Hippel-Lindau disease. A case report].
    Martínez-Miravete P; Domínguez P; Zubieta JL; Manrique M
    Radiologia; 2007; 49(4):287-9. PubMed ID: 17594893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multidisciplinary approach to the endolymphatic sac tumour].
    González-Bonet LG; Amoros-Sebastiá LI; Piquer-Belloch J; Riesgo P; Llacer JL; Gisbert-Aguilar J; Morell-Quadreny L
    Neurocirugia (Astur); 2011 Dec; 22(6):567-73. PubMed ID: 22167288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endolymphatic sac tumours and von Hippel-Lindau disease - case report, molecular analysis and histopathological characterization.
    Krzysztolik K; Cybulski C; Sagan L; Nowacki P; Lubiński J
    Folia Neuropathol; 2009; 47(1):75-80. PubMed ID: 19353437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature.
    Talukdar R; Epari S; Sahay A; Choudhari A; Dasgupta A; Chatterjee A; Gupta T
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2591-2598. PubMed ID: 34410472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT.
    Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
    Clin Nucl Med; 2016 Oct; 41(10):783-4. PubMed ID: 27454593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease.
    Butman JA; Kim HJ; Baggenstos M; Ammerman JM; Dambrosia J; Patsalides A; Patronas NJ; Oldfield EH; Lonser RR
    JAMA; 2007 Jul; 298(1):41-8. PubMed ID: 17609489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone.
    Mendenhall WM; Suárez C; Skálová A; Strojan P; Triantafyllou A; Devaney KO; Williams MD; Rinaldo A; Ferlito A
    Adv Ther; 2018 Jul; 35(7):887-898. PubMed ID: 29923043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endolymphatic sac tumor demonstrated by intralabyrinthine hemorrhage. Case report.
    Jagannathan J; Butman JA; Lonser RR; Vortmeyer AO; Zalewski CK; Brewer C; Oldfield EH; Kim HJ
    J Neurosurg; 2007 Aug; 107(2):421-5. PubMed ID: 17695400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
    Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
    Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature].
    de Minteguiaga C; García Ibáñez L; Tran Ba Huy P
    Acta Otorrinolaringol Esp; 2002; 53(7):515-20. PubMed ID: 12487074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endolymphatic sac tumors: experience of three cases.
    Bastier PL; de Mones E; Marro M; Elkhatib W; Franco-Vidal V; Liguoro D; Darrouzet V
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1551-7. PubMed ID: 23212692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and treatment of endolymphatic sac tumor.
    Bae SH; Kim SS; Kwak SH; Jung JS; Choi JY; Moon IS
    Acta Otolaryngol; 2020 Jun; 140(6):433-437. PubMed ID: 32068496
    [No Abstract]   [Full Text] [Related]  

  • 39. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
    Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
    Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease.
    Jagannathan J; Lonser RR; Stanger RA; Butman JA; Vortmeyer AO; Zalewski CK; Brewer C; Surowicz C; Kim HJ
    Otol Neurotol; 2007 Oct; 28(7):927-30. PubMed ID: 17468670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.